POPULATION PHARMACOKINETICS OF KRN23, A HUMAN ANTI-FGF23 ANTIBODY DEVELOPED FOR THE TREATMENT OF ADULTS WITH X-LINKED HYPOPHOSPHATEMIA.

Zhang X.; Peyret T.; Gosselin N. H.; Marier J.; Ito T.; Imel E.; Carpenter T. O.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >POPULATION PHARMACOKINETICS OF KRN23, A HUMAN ANTI-FGF23 ANTIBODY DEVELOPED FOR THE TREATMENT OF ADULTS WITH X-LINKED HYPOPHOSPHATEMIA.

【24h】

POPULATION PHARMACOKINETICS OF KRN23, A HUMAN ANTI-FGF23 ANTIBODY DEVELOPED FOR THE TREATMENT OF ADULTS WITH X-LINKED HYPOPHOSPHATEMIA.

机译：KRN23的种群药代动力学，KRN23是一种人类抗FGF23抗体，用于治疗X连锁低血血症的成人。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2015年第s1期|共1页
作者
Zhang X.; Peyret T.; Gosselin N. H.; Marier J.; Ito T.; Imel E.; Carpenter T. O.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. POPULATION PHARMACOKINETICS OF KRN23, A HUMAN ANTI-FGF23 ANTIBODY DEVELOPED FOR THE TREATMENT OF ADULTS WITH X-LINKED HYPOPHOSPHATEMIA. [J] . Zhang X., Peyret T., Gosselin N. H., Clinical Pharmacology and Therapeutics . 2015,第S1期

机译：KRN23的种群药代动力学，KRN23是一种人类抗FGF23抗体，用于治疗X连锁低血血症的成人。
2. PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF HUMAN ANTI-FGF23 ANTIBODY (KRN23) AND SERUM PHOSPHORUS IN ADULTS WITH X-LINKED HYPOPHOSPHATEMIA. [J] . Zhang X., Gosselin N. H., Marier J., Clinical Pharmacology and Therapeutics . 2015,第S1期

机译：X连锁性低磷血症成人的人抗FGF23抗体（KRN23）和血清磷的药动学/药代动力学模型。
3. Population pharmacokinetic and pharmacodynamic analyses from a 4-month intradose escalation and its subsequent 12-month dose titration studies for a human monoclonal anti-FGF23 antibody (KRN23) in adults with X-linked hypophosphatemia [J] . Zhang Xiaoping, Peyret Thomas, Gosselin Nathalie H., The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2016,第4期

机译：成人X连锁性低磷血症的人单克隆抗FGF23抗体（KRN23）的4个月内剂量递增及其随后12个月剂量滴定研究的人群药代动力学和药效学分析
4. Study of population and covariate model in physiologically based pharmacokinetics model used for treatment planning in peptide receptor radionuclide therapy [C] . Ade Riana, Supriyanto A. Pawiro, Deni Hardiansyah National Physics Seminar . 2020

机译：肽受体放射性核素治疗治疗计划的生理基于药代动力学模型的人口与协变化模型研究
5. Developing patient specific population pharmacokinetic models and comparing compartmental vs. non-compartmental analysis for the prediction of individual pharmacokinetic parameters. [D] . Hines, Daniel Joseph. 2009

机译：开发患者特定人群的药代动力学模型并比较隔室与非隔室分析，以预测各个药代动力学参数。
6. Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia [O] . Mary D. Ruppe, Xiaoping Zhang, Erik A. Imel, 2016

机译：每月四剂人源抗FGF23单克隆抗体（KRN23）对X连锁性低磷血症患者生活质量的影响
7. Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia [O] . Ruppe Mary D., Zhang Xiaoping, Imel Erik A., 2016

机译：每月四剂人源抗FGF23单克隆抗体（KRN23）对X连锁性低磷血症患者生活质量的影响

POPULATION PHARMACOKINETICS OF KRN23, A HUMAN ANTI-FGF23 ANTIBODY DEVELOPED FOR THE TREATMENT OF ADULTS WITH X-LINKED HYPOPHOSPHATEMIA.

著录项

相似文献

相关主题

期刊订阅